Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content
Fig. 5 | Immunity & Ageing

Fig. 5

From: B-1 derived anti-Thy-1 B cells in old aged mice develop lymphoma/leukemia with high expression of CD11b and Hamp2 that different from TCL1 transgenic mice

Fig. 5

12 mo TCCD5 down ATA B spleen++ cells similar to old aged TCATA B lymphoma/leukemia. TC+ Tg ATA B lymphoma/leukemia are NF-kB1 high. Old aged TC ATA B are CD11b++CD22++, CD24low, and Hamp2++ generation, and V8-12 with Vk19 AGcA MZ B are 12 mo Hamp2+ and old age generated macrophage++ with intestinal tumor. A and B. 12 mo TCCD5 ATA B with spleen++ generate similar to old aged TCCD5ATA B tumor. TC+Tg ATA B CLL/lymphoma are higher NF-kB and TCL1 induced miR21 and miR155 and down miR29. C TC lymphoma/leukemia showed CD11b++CD22++ and generate Hamp2++ (TCZAP70 are more IL10 and IL-6, and TCZAP70+ are high IL-22R) with iron down, as USF2+, TFR+, FPN. D TC ATA B lymphoma/leukemia generated high Hamp2 and CD44++CD24low. Human V2-5 positive papers, as kidney, Breast cancer, Pancreatic cancer, SARS-CoV-2, and SLE. Breast cancer are CD44++CD24lo. E Some ATA B tumor showed together with high myeloid cells (CD11b+Gr-1+) [13], and VH8-12/Vk19 AGcA generate MZ B with Hamp2+ in 12 mo, then old aged generate macrophages++ in spleen with intestine/color tumor++

Back to article page